Knight Therapeutics Company Description

Knight Therapeutics Inc. operates as a specialty pharmaceutical company that focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing pharmaceutical products in Canada and Latin America.

The company was founded in 2014 and is based in Montreal, Canada. It operates in additional locations in Latin America, such as Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Mexico, Paraguay, Peru, and Uruguay.

Knight Therapeutics Inc.

Country	Canada
Founded	2014
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	725
CEO	Samira Sakhia

Contact Details

Address: 3400 de Maisonneuve Blvd. W. Montreal, QC H3Z 3B8 Canada
Phone	514-484-4483
Website	knighttx.com

Stock Details

Ticker Symbol	GUD
Exchange	Toronto Stock Exchange
Fiscal Year	January - December
Reporting Currency	CAD
ISIN Number	CA4990531069
SIC Code	2834

Key Executives

Name	Position
Samira Sakhia BCom, CA, CPA, MBA	President, Chief Executive Officer and Director
Jonathan Ross Goodman B.A., L.L.B., M.B.A.	Executive Chairman
Arvind Utchanah	Chief Financial Officer
Amal Khouri B.Sc., M.B.A.	Chief Business Officer
Stephani Saverio	Vice President of Business Development
Leopoldo Bosano	Vice-President of Manufacturing and Operations
Henrique Dias	Global Director of Marketing
Susan Caroline Emblem	Global Vice President of Human Resources
Jeff Martens	Global Vice President of Commercial
Melanie Groleau	Global Vice President of Medical and Clinical